The Providence Projects has been acquired by UKAT Group

July 2025 — Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.

Established in 1996, The Providence Projects is one of the UK’s leading providers of affordable private alcohol and drug rehabilitation services. With nearly three decades of experience, Providence has built a strong reputation for delivering high-quality, accessible care to individuals and families affected by addiction. Based in Bournemouth, the group offers a comprehensive range of evidence-based treatments for substance misuse, including alcohol, cocaine, heroin, prescription drugs and behavioral addictions such as gambling. The Providence team is made up of highly experienced addiction specialists, therapists and support staff, all committed to helping clients achieve lasting recovery.

Treatment at Providence is centered around compassion, respect and clinical excellence. Programs are personalized and combine one-to-one therapy, group counseling, cognitive behavioral therapy (CBT), 12-step facilitation and holistic treatments, all tailored to the specific needs of each individual. Detox services are medically supervised, with aftercare planning forming a core component of their relapse prevention approach. The Providence Projects also offers a range of supported accommodation options and provides extensive family support services to ensure a well-rounded recovery journey. Over the years, Providence has helped thousands of clients transform their lives and continues to be recognized for its commitment to affordability, professionalism and long-term outcomes.

UKAT Group is a nationwide network of Care Quality Commission (CQC)-regulated rehabilitation clinics, dedicated to providing high-quality, evidence-based addiction treatment. Their mission is to help individuals achieve long-term recovery through professional medical detox, rehabilitation therapy and ongoing support. UKAT offers treatment for a wide range of substance and behavioral addictions, including alcohol and drug addiction, gambling addiction, eating disorders and dual diagnosis involving co-occurring mental health conditions.

Our role in the transaction

Oaklins S&W, based in the UK, acted as the lead advisor to the shareholders on the sale of the business to UKAT. Its strong sector credentials enabled it to win a competitive pitch process. The team subsequently advised on all aspects of the transaction, from initial buyer research and sale preparation to drafting marketing materials, leading negotiations and buyer meetings, managing due diligence and overseeing general project management throughout the deal.